Skip to main content
OpenTrials

Clinical trial condition

Immunoproliferative Disorders

Explore clinical trials studying Immunoproliferative Disorders. Study availability and eligibility vary by location and protocol.

9,947 public trials 2,015 recruiting studies
Refine in advanced search Browse all conditions

Immunoproliferative Disorders trial results

Active, Not Recruiting

Ribociclib in Combination With Everolimus and Dexamethasone in Relapsed ALL

NCT03740334

Conditions
Acute Lymphoblastic Leukemia ALL, Hematologic Diseases, Hemic and Lymphatic Diseases, +9 more
Locations
  • Children's Hospital Colorado Aurora, Colorado, United States
  • Nemours/Alfred I. duPont Hospital for Children Wilmington, Delaware, United States
  • Children's Healthcare of Atlanta Atlanta, Georgia, United States
  • Boston Children's Hospital Boston, Massachusetts, United States
View Trial Details
Active, Not Recruiting

Personalized Risk Stratification Model of Follicular Lymphoma Patients

NCT03436602

Conditions
Follicular Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
Locations
  • Arcispedale Santa Maria Nuova, AUSL IRCSS, Hematology Department Reggio Emilia, RE, Italy
  • Azienda Ospedaliera Universitaria Maggiore della Carità Novara, Italy
  • Institute of Oncology Research Bellinzona, Canton Ticino, Switzerland
  • Institute of Pathology Locarno, Canton Ticino, Switzerland
View Trial Details
Active, Not Recruiting

Brentuximab Vedotin and Combination Chemotherapy in Treating Patients With CD30-Positive Peripheral T-cell Lymphoma

NCT03113500

Conditions
Adult T-Cell Leukemia/Lymphoma, Anaplastic Large Cell Lymphoma, ALK-Positive, Anaplastic Large Cell Lymphoma, ALK-negative, +26 more
Locations
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • Hackensack University Medical Center Hackensack, New Jersey, United States
  • Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States
  • M D Anderson Cancer Center Houston, Texas, United States
View Trial Details
Active, Not Recruiting

A Study of Cobolimab Plus Dostarlimab in Pediatric and Young Adult Participants With Cancer

NCT06521567

Conditions
Adenocarcinoma, Astrocytoma, Brain Diseases, +56 more
Locations
  • GSK Investigational Site Los Angeles, California, United States
  • GSK Investigational Site Iowa City, Iowa, United States
  • GSK Investigational Site Hackensack, New Jersey, United States
  • GSK Investigational Site Cincinnati, Ohio, United States
View all 20 locations
View Trial Details
Active, Not Recruiting

A Study of Brentuximab Vedotin + Adriamycin, Vinblastine, and Dacarbazine in Pediatric Participants With Advanced Stage Newly Diagnosed Hodgkin Lymphoma

NCT02979522

Conditions
Hemic and Lymphatic Diseases, Hodgkin Disease, Immune System Diseases, +6 more
Locations
  • Children's Hospital Colorado Aurora, Colorado, United States
  • Cincinnati Children's Hospital Medical Center Cincinnati, Ohio, United States
  • Hospital Sao Rafael S/A Salvador, Estado de Bahia, Brazil
  • Jardim das Americas Paranã, Brazil
View all 14 locations
View Trial Details
Active, Not Recruiting

huCART19-IL18 in CD19+ Cancers

NCT04684563

Conditions
Acute Lymphoblastic Leukemia, Chronic Disease, Chronic Lymphocytic Leukemia, +19 more
Locations
  • University of Pennsylvania Philadelphia, Pennsylvania, United States
View Trial Details
Active, Not Recruiting

Phase II Study of IRD (Ixazomib, Lenalidomide, Dexamethasone) Post Autologous Stem Cell Transplantation Followed by Maintenance Ixazomib or Lenalidomide for Multiple Myeloma

NCT02253316

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • City of Hope Duarte, California, United States
  • University of California, San Francisco San Francisco, California, United States
  • Colorado Blood Cancer Institute Denver, Colorado, United States
  • Emory University - Winship Cancer Institute Atlanta, Georgia, United States
View Trial Details

Related conditions